Search by Drug Name or NDC

    NDC 11822-0096-01 severe cold cough and flu relief 650; 20; 10 mg/1; mg/1; mg/1 Details

    severe cold cough and flu relief 650; 20; 10 mg/1; mg/1; mg/1

    severe cold cough and flu relief is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 11822-0096
    Product ID 11822-0096_127990bb-c4d9-4ff2-8012-c1129c2ec4a9
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name severe cold cough and flu relief
    Proprietary Name Suffix daytime
    Non-Proprietary Name Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Rite Aid Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 11822-0096-01 (11822009601)

    NDC Package Code 11822-0096-1
    Billing NDC 11822009601
    Package 6 POWDER, FOR SOLUTION in 1 CARTON (11822-0096-1)
    Marketing Start Date 2015-08-05
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9f29822e-dbfe-49c4-b13e-44f443dbf513 Details

    Revised: 11/2022